We are at Mibelle involved in the Oleaf4Value project in possible encapsulations and formulations of the different extracts, focusing in the generation for liposomes towards market applications.A liposome is a small vesicle composed of a lipid double layer. It is formed through a process called self-assembly, where the lipids arrange themselves in a specific manner
The MLU uses the nematode Caenorhabditis elegans (figure 1) as a simple and well-established model organism to analyze the bioactivity of olive leaf extracts. The different extracts generated in the OLEAF4VALUE project (figure 2) have to be investigated concerning possible beneficial effects (high „bioactivity“) to find new innovative applications, e.g. in pharmaceutical
At NIZO we have been working on the optimization of our in vitro technologies for the assessment of potential health benefits of plant extracts. In parallel, a small number of olive leaf extracts and pure polyphenols have already been tested. We applied our Gut Health Discovery Platform (GHDP), starting with fecal batch fermentations in
The pharmaceutical technique research group of University of Florence (UNIFI) developed different nanocarriers (microemulsions, solid dispersions and polymeric micelles) to enhance solubility, permeability and pharmaceutical properties of oleanolic acid (OA), a triterpene enriched extract (TTPs ext) and an oleuropein extract (OLE) (Figure 1). All these formulations were tested in terms of water solubility, storage
In Arquebio, we’ve been testing different strains of fungi for their innate ability to produce valuable derivatives of oleanolic acid. Fungi possess a unique ability to generate hydroxylated derivatives of triterpene-related molecules, among other interesting interactions. Recently, we discovered that the fungi Absidia cylindrospora transforms oleanolic acid into a variety of unidentified compounds, some
Halfway through OLEAF4VALUE: from the valorisation of olive leaves to the exploitation of high value-added biobased products OLEAF4VALUE is a BBI-JU, H2020-funded EU project that aims to extend the useful life of olive leaves, solving the problem of their removal from the fields while obtaining high added-value bioactive products with high-market potential. The project will
IPB group has developed different Molecularly Imprinted Polymers (MIPs) to aid with the production of tailor made bioproducts from diverse olive leaf extracts. The IPB work comprise the design, synthesis, characterization and testing of MIPs to target secoiridoids, triterpenic acids, flavonoids and lignans. The developed MIP particles were tested with the processing of different kinds
The Biomass Area of CENER (National Renewable Energy Centre of Spain) is convinced of the need to move towards a circular bioeconomy, in which the society is capable of valorising the wastes produced in an integral and cascade mode. On that regard, CENER is running its Biorefinery and Bioenergy Centre (BIO2C), semi-industrial pilot scale test
Written by Albert Kravos, InnoRenew CoE Located in the Istrian region of Slovenia is nestled a farm enveloped in nature, here an olive orchard dwells in a land treated with respect and the faith that organic practices can and will return agriculture to a more sustainable, healthy, and productive way of living,
About Ingecor Founded in 2006, has its origins in the agroforestry management of the land. Ingecor's founding team has more than 15 years of experience in the forestry and agricultural sector. Its principal activity is this moment is management, storage and logistics of biomass for supply to electric power production plant.
This project has received funding from the Bio-Based Industries Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme under grant agreement nº 101023256
This project has received funding from the Bio-Based Industries Joint Undertaking under the European Union’s Horizon 2020 research and innovation programme under grant agreement nº 101023256
©COPYRIGHT 2025 | PRIVACY POLICY | ALL RIGHTS RESERVED | COOKIE POLICY
